Exact Sciences Shares Are Trading Higher After the Company Shared New Modeling Data on the Projected Impact of Its Cologuard Test Since Its FDA Approval
精密科學股票上漲,公司發佈了其Cologuard試驗獲得FDA批准後的新模擬數據預計將產生的影響。
Exact Sciences Shares Are Trading Higher After the Company Shared New Modeling Data on the Projected Impact of Its Cologuard Test Since Its FDA Approval
精密科學股票上漲,公司發佈了其Cologuard試驗獲得FDA批准後的新模擬數據預計將產生的影響。
使用瀏覽器的分享功能,分享給你的好友吧